336 related articles for article (PubMed ID: 2201437)
21. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene.
Culp SJ; Warbritton AR; Smith BA; Li EE; Beland FA
Carcinogenesis; 2000 Jul; 21(7):1433-40. PubMed ID: 10874023
[TBL] [Abstract][Full Text] [Related]
22. 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II.
Pfau W; Schmeiser HH; Wiessler M
Carcinogenesis; 1990 Sep; 11(9):1627-33. PubMed ID: 2401053
[TBL] [Abstract][Full Text] [Related]
23. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR.
Arlt VM; Schmeiser HH; Pfeifer GP
Carcinogenesis; 2001 Jan; 22(1):133-40. PubMed ID: 11159751
[TBL] [Abstract][Full Text] [Related]
24. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.
Chen B; Liu L; Castonguay A; Maronpot RR; Anderson MW; You M
Carcinogenesis; 1993 Aug; 14(8):1603-8. PubMed ID: 8353844
[TBL] [Abstract][Full Text] [Related]
25. Absence of Ki-ras mutations in exocrine pancreatic tumors from male rats chronically exposed to gabapentin.
Fowler ML; Sigler RE; de la Iglesia FA; Reddy JK; Lalwani ND
Mutat Res; 1995 Mar; 327(1-2):151-60. PubMed ID: 7870083
[TBL] [Abstract][Full Text] [Related]
26. Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase alpha.
Broschard TH; Wiessler M; Schmeiser HH
Cancer Lett; 1995 Nov; 98(1):47-56. PubMed ID: 8529205
[TBL] [Abstract][Full Text] [Related]
27. Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and K-Ras mutant fraction.
Wang Y; Meng F; Arlt VM; Mei N; Chen T; Parsons BL
Mutagenesis; 2011 Sep; 26(5):619-28. PubMed ID: 21642617
[TBL] [Abstract][Full Text] [Related]
28. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
29. Both (+/-)syn- and (+/-)anti-7,12-dimethylbenz[a]anthracene-3,4-diol-1,2-epoxides initiate tumors in mouse skin that possess -CAA- to -CTA- mutations at Codon 61 of c-H-ras.
Tang MS; Vulimiri SV; Viaje A; Chen JX; Bilolikar DS; Morris RJ; Harvey RG; Slaga TJ; DiGiovanni J
Cancer Res; 2000 Oct; 60(20):5688-95. PubMed ID: 11059761
[TBL] [Abstract][Full Text] [Related]
30. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression.
Brown K; Buchmann A; Balmain A
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):538-42. PubMed ID: 2105486
[TBL] [Abstract][Full Text] [Related]
31. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases.
Schmeiser HH; Frei E; Wiessler M; Stiborova M
Carcinogenesis; 1997 May; 18(5):1055-62. PubMed ID: 9163696
[TBL] [Abstract][Full Text] [Related]
32. Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors.
McMahon G; Davis EF; Huber LJ; Kim Y; Wogan GN
Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1104-8. PubMed ID: 2105496
[TBL] [Abstract][Full Text] [Related]
33. Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene.
Hayashi S; Mori I; Nonoyama T; Mitsumori K
Toxicol Pathol; 1998; 26(4):556-61. PubMed ID: 9715515
[TBL] [Abstract][Full Text] [Related]
34. Sequencing analysis of Ha-, Ki-, and N-ras genes in rat urinary bladder tumors induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) and sodium saccharin.
Masui T; Mann AM; Borgeson CD; Garland EM; Okamura T; Fujii H; Pelling JC; Cohen SM
Teratog Carcinog Mutagen; 1993; 13(5):225-33. PubMed ID: 7905676
[TBL] [Abstract][Full Text] [Related]
35. ras gene activation in rat tumors induced by benzidine congeners and derived dyes.
Reynolds SH; Patterson RM; Mennear JH; Maronpot RR; Anderson MW
Cancer Res; 1990 Jan; 50(2):266-72. PubMed ID: 2403837
[TBL] [Abstract][Full Text] [Related]
36. Low frequency of H-ras activation in naturally occurring hepatocellular tumors of C3H/HeNCr mice.
Enomoto T; Weghorst CM; Ward JM; Anderson LM; Perantoni AO; Rice JM
Carcinogenesis; 1993 Sep; 14(9):1939-44. PubMed ID: 8403222
[TBL] [Abstract][Full Text] [Related]
37. Analysis of activated protooncogenes in B6C3F1 mouse liver tumors induced by ciprofibrate, a potent peroxisome proliferator.
Hegi ME; Fox TR; Belinsky SA; Devereux TR; Anderson MW
Carcinogenesis; 1993 Jan; 14(1):145-9. PubMed ID: 8425263
[TBL] [Abstract][Full Text] [Related]
38. Activating point mutation in Ki-ras codon 63 in a chemically induced rat renal tumor.
Higinbotham KG; Rice JM; Perantoni AO
Mol Carcinog; 1992; 5(2):136-9. PubMed ID: 1554412
[TBL] [Abstract][Full Text] [Related]
39. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.
Buchmann A; Bauer-Hofmann R; Mahr J; Drinkwater NR; Luz A; Schwarz M
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):911-5. PubMed ID: 1992483
[TBL] [Abstract][Full Text] [Related]
40. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.
Arlt VM; Stiborova M; Schmeiser HH
Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
